Threadneedle UK Equity Alpha Income Retail Income 
Overview
| Fund manager's initial charge | 3.75% |
|---|---|
| HL initial saving | 3.75% |
| Net initial charge | 0.00% |
| Dealing charge | Free |
| Fund manager's annual charge | 1.50% |
| Performance charges | No |
| Total Expense Ratio | 1.62% |
| HL annual saving | 0.00% 2 |
| Platform fee | Free |
| Launch date | 08-05-2006 |
| Launch price | £0.50 |
| Sector | UK Equity Income |
| Fund size | £242.00 million |
| Number of holdings | 34 |
| Fund type | OEIC |
| Type of units | Income |
Please read the Simplified Prospectus/Key Investor Information Document in addition to the information above.
Invest online now
Before you invest please read the key features and Simplified Prospectus/Key Investor Information Document for more details.
HL research - our view on this fund
Leigh Harrison currently favours companies such as GlaxoSmithKline and Imperial Tobacco, which are industry leaders insulated from competition and have the protection of high barriers to entry. He also likes businesses that are restructuring, with the potential to recover strongly. This strategy is proving rewarding.
About the Fund Manager
Leigh Harrison
Located in: London
Leigh Harrison is Threadneedle's Head of UK Equities and has overall responsibility for the management and performance of UK equity products. As Head of the UK Equity team, Leigh places a particular focus on UK retail products. Leigh manages the Threadneedle UK Equity Alpha Income Fund and the Threadneedle UK Equity Income Fund. Prior to joining Threadneedle, Leigh was a director and senior portfolio manager for UK equities at Credit Suisse Asset Management where he built an outstanding reputation for UK equity income products. He has also held the positions of associate director at Rowan Dartington and director at Hill Samuel Investment Management where he focused on UK smaller company funds. Leigh holds a BA (Hons) from Nottingham University and an MSc from University College, London. He is also a Member of the Securities Institute.
1 of 2 
Income details
| Historic yield | 4.60% |
|---|---|
| Income paid | Bi-annually |
| Type of payment | Dividend |
All yields are variable and not guaranteed. Information as at 31-12-2011.
Distribution dates
| Ex-dividend date | 01 May 2012 |
|---|---|
| Payment date 4 | 30 June 2012 |
1 of 2
Top 10 holdings
| GlaxoSmithKline | 7.49% |
|---|---|
| Royal Dutch Shell B | 7.01% |
| BT Group | 6.37% |
| AstraZeneca | 6.11% |
| British American Tobacco | 5.08% |
| Unilever | 5.05% |
| Reed Elsevier | 4.91% |
| Legal & General Group | 4.83% |
| Centrica | 4.65% |
| Imperial Tobacco Group | 4.65% |
Top 10 sectors
| Pharmaceuticals & Biotechnology | 13.61% |
|---|---|
| Tobacco | 9.73% |
| Oil & Gas Producers | 9.52% |
| Life Insurance | 8.93% |
| Gas, Water & Multiutilities | 8.80% |
| Travel & Leisure | 7.93% |
| Fixed Line Telecommunications | 6.37% |
| Food Producers | 5.05% |
| Media | 4.91% |
| Aerospace & Defence | 4.59% |
Top 10 countries
| United Kingdom | 99.96% |
|---|---|
| Cash and Equiv. | 0.04% |
Some of the data on this page and other related pages is provided to you for your information and is received from the Fund Management Company administering this fund. Hargreaves Lansdown accepts no liability for the reliability or accuracy of the data provided by third parties.
2 Annual saving is not available in the SIPP or Junior ISA.
4 If you elect to receive the income from a Vantage ISA, Fund or Share Account, we will collect any dividends for you and then pay them directly into your bank account within the first 10 working days of the following month.
Prices as at 09-02-2012. Data as at 31/12/2011.
